← HDFC Mutual Fund

HDFC MNC Fund - Growth Option - Direct Plan

Equity Data as of Jun 2026 Comparing May 2026 → Jun 2026
Share: WhatsApp X
Stocks Held
38
Jun 2026
Equity Holdings
₹532.79 Cr
Equity only, excl. debt & cash
Top 5 Weight
35.9%
Moderate
Top 10 Weight
53.1%
Moderate
Changes
44
7 new · 7 exits
Top Sector
Pharmaceuticals & Biotechnology
17.8% of portfolio
📋 What Happened This Month HDFC MNC Fund made 7 new additions and exited 7 stocks this month. The biggest new buy was Ajanta Pharma Limited (Pharmaceuticals & Biotechnology) at 3.24% weight. Fortis Healthcare Limited was the biggest exit (Healthcare Services), which was held at 2.90%. Among existing holdings, Maruti Suzuki India Limited saw the biggest increase — now at 9.87% of the portfolio. Nestle India Limited was trimmed the most, now at 6.06%. Maruti Suzuki India Limited remains the top holding with Pharmaceuticals & Biotechnology the dominant sector at 17.8%. ↓ Scroll down for full holdings, sector allocation and month-on-month changes in detail.
Sector Shift Industry allocation month-over-month
Apr 2026 May 2026
Sector Prev Curr Delta
Food Products 16.5% 14.4% -2.1%
Pharmaceuticals & Biotechnology 8.7% 13.3% +4.6%
Industrial Products 11.2% 12.6% +1.4%
Automobiles 7.9% 10.9% +3.1%
Electrical Equipment 0.0% 10.6% +10.6%
Auto Components 8.6% 5.6% -3.0%
Agricultural, Commercial & Construction Vehicles 4.1% 5.5% +1.3%
Diversified FMCG 7.2% 5.0% -2.2%
Beverages 4.9% 3.7% -1.2%
Healthcare Services 6.4% 2.9% -3.5%
May 2026 Jun 2026
Sector Prev Curr Delta
Pharmaceuticals & Biotechnology 13.3% 17.8% +4.5%
Automobiles 10.9% 12.9% +2.0%
Food Products 14.4% 12.7% -1.7%
Industrial Products 12.6% 10.2% -2.4%
Electrical Equipment 10.6% 8.9% -1.7%
Diversified FMCG 5.0% 6.8% +1.8%
Agricultural, Commercial & Construction Vehicles 5.5% 5.7% +0.2%
Auto Components 5.6% 4.4% -1.2%
Beverages 3.7% 3.9% +0.2%
Metals & Minerals Trading 0.0% 3.1% +3.1%
🟢
Biggest New Buy
Ajanta Pharma Limited
3.24% weight · Pharmaceuticals & Biotechnology
🔴
Biggest Exit
Fortis Healthcare Limited
2.90% was held · Healthcare Services
Biggest Add
Maruti Suzuki India Limited
+2.03% · now 9.87%
Biggest Trim
Nestle India Limited
-1.51% · now 6.06%
🤝 Other funds also bought this month
Vedanta Aluminium Metal Limited 43 funds
Vedanta Aluminium Metal Limited
Tata Resources & Energy Fund-Direct Plan-Growth
Kotak MNC Fund-Direct Plan-Growth
Baroda BNP Paribas Dividend Yield Fund + more
Ajanta Pharma Limited 22 funds
Ajanta Pharma Limited
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan
Kotak Dividend Yield Fund
Aditya Birla Sun Life Special Opportunities Fund-Direct-Growth + more
LG Electronics India Ltd 15 funds
LG Electronics India Ltd
Kotak BSE Housing Index Fund - Direct Plan - Growth Option
UTI BSE Housing Index Fund - Direct Plan - Growth Option
quant Focused Fund - Growth Option-Direct Plan + more
Gland Pharma Limited 14 funds
Gland Pharma Limited
IB71-Groww Nifty Smallcap 250 Momentum Quality 100 Index Fund
IB70-Groww Nifty Smallcap 250 Momentum Quality 100 ETF
HSBC Large & Mid Cap Fund - Direct Growth + more
IPCA Laboratories Limited 8 funds
IPCA Laboratories Limited
Groww Value Fund (formerly known as Indiabulls Value Fund) - Direct Plan - Growth Option
Sundaram Multi-Factor Fund - Direct - Growth
Bandhan Nifty Midcap 150 Index Fund-Direct Plan-Growth + more
AWL Agri Business Limited 7 funds
AWL Agri Business Limited
UTI Nifty 500 Value 50 Index Fund - Direct Plan - Growth Option
Mirae Asset Nifty 500 Value 50 ETF
Bandhan Nifty 500 Value 50 Index Fund + more
👋 Other funds also exited
Fortis Healthcare Limited 29 funds
Fortis Healthcare Limited
Groww BSE Hospitals ETF
Kotak Nifty 200 Momentum 30 Index Fund - Direct Plan - Growth Option
Baroda BNP Paribas Nifty200 Momentum 30 Index Fund - Direct Plan - Growth Option + more
Sona BLW Precision Forgings Limited 14 funds
Sona BLW Precision Forgings Limited
GROWW NIFTY EV & NEW AGE AUTOMOTIVE ETF
Mirae Asset BSE Select IPO ETF
UTI Nifty Midcap 150 Quality 50 Index Fund - Direct Plan - Growth Option + more
Abbott India Limited 13 funds
Abbott India Limited
Union Midcap Fund - Direct Plan - Growth Option
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth
NJ Flexi Cap Fund + more
Pfizer Limited 9 funds
Pfizer Limited
DSP Nifty Smallcap250 Quality 50 Index Fund - Direct - Growth
Baroda BNP Paribas Small Cap Fund - Direct Plan - Growth option
Baroda BNP Paribas Innovation Fund Direct plan - Growth Option + more
Sai Life Sciences Limited 4 funds
Sai Life Sciences Limited
Mirae Asset BSE Select IPO ETF
Groww Nifty Smallcap250 ETF
Mirae Asset Multi Asset Allocation Fund + more

What Changed in the Portfolio This Month?

Comparing May 2026 → Jun 2026

May 2026 Jun 2026
🟢 7 New Entries 🔴 7 Exits ↑ 13 Increased ↓ 17 Decreased
#StockSectorWeight (Jun 2026)
1
Ajanta Pharma Limited
₹17.49 Cr
Pharmaceuticals & Biotechnology 3.24%
2
Vedanta Aluminium Metal Limited
₹16.82 Cr
Metals & Minerals Trading 3.11%
3
Gland Pharma Limited
₹10.85 Cr
Pharmaceuticals & Biotechnology 2.01%
4
LG Electronics India Ltd
₹9.56 Cr
Consumer Durables 1.77%
5
IPCA Laboratories Limited
₹8.51 Cr
Pharmaceuticals & Biotechnology 1.57%
6
Colgate Palmolive (India) Limited
₹5.19 Cr
Personal Products 0.96%
7
AWL Agri Business Limited
₹3.21 Cr
Agricultural Food & other Products 0.59%
#StockSectorLast Weight (May 2026)
1
Fortis Healthcare Limited
₹15.42 Cr
Healthcare Services 2.90%
2
Pfizer Limited
₹9.84 Cr
Pharmaceuticals & Biotechnology 1.85%
3
Grindwell Norton Limited
₹9.42 Cr
Industrial Products 1.77%
4
Sona BLW Precision Forgings Limited
₹6.39 Cr
Auto Components 1.20%
5
Abbott India Limited
₹5.43 Cr
Pharmaceuticals & Biotechnology 1.02%
6
Sai Life Sciences Limited
₹1.74 Cr
Pharmaceuticals & Biotechnology 0.33%
7
Goodyear India Ltd.
₹1.21 Cr
Auto Components 0.23%
#StockSectorMay 2026Jun 2026Change
1
Maruti Suzuki India Limited
₹53.30 Cr
Automobiles 7.84% 9.87% +2.03%
2
Hindustan Unilever Limited
₹36.90 Cr
Diversified FMCG 5.03% 6.83% +1.80%
3
Neuland Laboratories Limited
₹12.17 Cr
Pharmaceuticals & Biotechnology 1.58% 2.25% +0.67%
4
Cipla Limited
₹8.41 Cr
Pharmaceuticals & Biotechnology 0.98% 1.56% +0.58%
5
Divi's Laboratories Limited
₹4.08 Cr
Pharmaceuticals & Biotechnology 0.38% 0.76% +0.38%
6
Wockhardt Limited
₹5.58 Cr
Pharmaceuticals & Biotechnology 0.67% 1.03% +0.36%
7
Pearl Global Industries Limited
₹11.60 Cr
Textiles & Apparels 1.84% 2.15% +0.31%
8
Bosch Limited
₹17.80 Cr
Auto Components 3.07% 3.29% +0.22%
9
Tata Motors Ltd
₹12.18 Cr
Agricultural, Commercial & Construction Vehicles 2.06% 2.25% +0.19%
10
United Spirits Limited
₹20.82 Cr
Beverages 3.68% 3.85% +0.17%
#StockSectorMay 2026Jun 2026Change
1
Nestle India Limited
₹32.75 Cr
Food Products 7.57% 6.06% -1.51%
2
Anthem Biosciences Limited
₹12.72 Cr
Pharmaceuticals & Biotechnology 3.43% 2.35% -1.08%
3
GE Vernova T&D India Limited
₹14.93 Cr
Electrical Equipment 3.52% 2.76% -0.76%
4
Ambuja Cements Limited
₹5.17 Cr
Cement & Cement Products 1.64% 0.96% -0.68%
5
ABB India Limited
₹11.70 Cr
Electrical Equipment 2.75% 2.17% -0.58%
6
Vedanta Limited
₹10.53 Cr
Diversified Metals 2.49% 1.95% -0.54%
7
Nippon Life India Asset Management Limited
₹5.53 Cr
Capital Markets 1.55% 1.02% -0.53%
8
Cummins India Limited
₹34.73 Cr
Industrial Products 6.79% 6.43% -0.36%
9
Timken India Limited
₹20.49 Cr
Industrial Products 4.02% 3.79% -0.23%
10
Britannia Industries Limited
₹35.98 Cr
Food Products 6.85% 6.66% -0.19%

What Stocks Does This Fund Hold?

38 stocks — Jun 2026

# Stock Sector Cap Weight & Value
1
₹53.30 Cr
Automobiles
9.87%
2
₹36.90 Cr
Diversified FMCG
6.83%
3
₹35.98 Cr
Food Products
6.66%
4
₹34.73 Cr
Industrial Products
6.43%
5
₹32.75 Cr
Food Products
6.06%
6
₹20.82 Cr
Beverages
3.85%
7
₹20.49 Cr
Industrial Products
3.79%
8
₹17.80 Cr
Auto Components
3.29%
9
₹17.49 Cr
Pharmaceuticals & Biotechnology
3.24%
10
₹16.82 Cr
Metals & Minerals Trading
3.11%
🏆 Top stocks held by Equity funds
See which stocks all active Equity fund managers are buying — ranked by total value invested
🏦 HDFC Mutual Fund — Portfolio & Holdings
See all funds managed by HDFC Mutual Fund — conviction stocks, monthly entries & exits

Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.

Found a discrepancy or have feedback? Contact Us — we read every message personally.